risperidone has been researched along with Fragile X Syndrome in 3 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Fragile X Syndrome: A condition characterized genotypically by mutation of the distal end of the long arm of the X chromosome (at gene loci FRAXA or FRAXE) and phenotypically by cognitive impairment, hyperactivity, SEIZURES, language delay, and enlargement of the ears, head, and testes. INTELLECTUAL DISABILITY occurs in nearly all males and roughly 50% of females with the full mutation of FRAXA. (From Menkes, Textbook of Child Neurology, 5th ed, p226)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The goal of this study was to assess the effectiveness of risperidone monoantipsychotic therapy targeting irritability in patients with Fragile X syndrome (FXS) in a naturalistic outpatient clinical setting." | 7.88 | Risperidone Treatment for Irritability in Fragile X Syndrome. ( Dominick, KC; Erickson, CA; Pedapati, EV; Shaffer, R; Sweeney, JA; Wink, LK, 2018) |
| "The goal of this study was to assess the effectiveness of risperidone monoantipsychotic therapy targeting irritability in patients with Fragile X syndrome (FXS) in a naturalistic outpatient clinical setting." | 3.88 | Risperidone Treatment for Irritability in Fragile X Syndrome. ( Dominick, KC; Erickson, CA; Pedapati, EV; Shaffer, R; Sweeney, JA; Wink, LK, 2018) |
| " They responded well to the reduction in dosage or to withdrawal of the apparent causing agent." | 2.49 | [Medication-related oculogyric crises: a description of four cases and a review of the literature]. ( Campistol, J; Darling, A; Perez-Duenas, B; Poo, P, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckert, EM | 1 |
| Dominick, KC | 2 |
| Pedapati, EV | 2 |
| Wink, LK | 2 |
| Shaffer, RC | 1 |
| Andrews, H | 1 |
| Choo, TH | 1 |
| Chen, C | 1 |
| Kaufmann, WE | 1 |
| Tartaglia, N | 1 |
| Berry-Kravis, EM | 1 |
| Erickson, CA | 2 |
| Shaffer, R | 1 |
| Sweeney, JA | 1 |
| Darling, A | 1 |
| Poo, P | 1 |
| Perez-Duenas, B | 1 |
| Campistol, J | 1 |
1 review available for risperidone and Fragile X Syndrome
| Article | Year |
|---|---|
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Ch | 2013 |
2 other studies available for risperidone and Fragile X Syndrome
| Article | Year |
|---|---|
Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional Analysis.
Topics: Adolescent; Adult; Aggression; Antidepressive Agents; Antipsychotic Agents; Child; Comorbidity; Cros | 2019 |
Risperidone Treatment for Irritability in Fragile X Syndrome.
Topics: Adolescent; Adult; Antipsychotic Agents; Child; Child, Preschool; Drug Therapy, Combination; Fragile | 2018 |